To encourage responsible and appropriate use of ICDs, CMS issued a Decision Memo for Implantable Defibrillators on January 27, 2005, indicating that ICDs will be covered for primary prevention of sudden cardiac death if the beneficiary is enrolled in either an FDA-approved category B IDE clinical trial (42 DFR ?405.201), a trial under the CMS Clinical Trial Policy (NCD Manual ?310.1) or a qualifying prospective data collection system (either a practical clinical trial or prospective systematic data collection, which is sometimes referred to as a registry).
US Code:
42 USC 1395y
Name of Law: Exclusions from Coverage and Medicare as a Secondary Payer
The data collection form has changed significantly to delete data elements and fields that were found to be no longer applicable. While some additional data elements were added due to the collection of important information regarding device lead placement, many fields also were greatly improved by better field descriptors and definitions. The majority of the increased time necessary to complete the data form is due to the additional data elements related to device lead placement.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.